These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9693761)
21. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM; Waller EK Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [TBL] [Abstract][Full Text] [Related]
22. Immature hematopoietic cells display selective requirements for adhesion- and degranulation-promoting adaptor protein in development and homeostatsis. Dluzniewska J; Zou L; Harmon IR; Ellingson MT; Peterson EJ Eur J Immunol; 2007 Nov; 37(11):3208-19. PubMed ID: 17948263 [TBL] [Abstract][Full Text] [Related]
23. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice. Szabo P; Zhao K; Kirman I; Le Maoult J; Dyall R; Cruikshank W; Weksler ME J Immunol; 1998 Sep; 161(5):2248-53. PubMed ID: 9725218 [TBL] [Abstract][Full Text] [Related]
24. Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. Klecha AJ; Genaro AM; Gorelik G; Barreiro Arcos ML; Silberman DM; Schuman M; Garcia SI; Pirola C; Cremaschi GA J Endocrinol; 2006 Apr; 189(1):45-55. PubMed ID: 16614380 [TBL] [Abstract][Full Text] [Related]
25. Demonstration of proliferation by bone marrow-derived lymphocytes of guinea pigs, mice and rabbits in response to mitogen stimulation in vitro. Elfenbein GJ; Harrison MR; Green I J Immunol; 1973 May; 110(5):1334-9. PubMed ID: 4540535 [No Abstract] [Full Text] [Related]
26. The H2(b) haplotype modifies the production of pro-inflammatory cytokines: implications for immunopathology. Matthews VB; Price P Eur Cytokine Netw; 2000 Dec; 11(4):640-6. PubMed ID: 11125308 [TBL] [Abstract][Full Text] [Related]
27. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus. Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829 [TBL] [Abstract][Full Text] [Related]
28. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Oberg L; Johansson S; Michaëlsson J; Tomasello E; Vivier E; Kärre K; Höglund P Eur J Immunol; 2004 Jun; 34(6):1646-53. PubMed ID: 15162434 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a B cell progenitor present in neonatal bone marrow and spleen but not in adult bone marrow and spleen. Moscatello KM; Biber KL; Dempsey DC; Chervenak R; Wolcott RM J Immunol; 1998 Nov; 161(10):5391-8. PubMed ID: 9820513 [TBL] [Abstract][Full Text] [Related]
30. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898 [TBL] [Abstract][Full Text] [Related]
31. Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNA. Li YY; Yang Y; Bao M; Edwards CK; Parnes JR Mol Immunol; 2006 Feb; 43(6):613-22. PubMed ID: 15899518 [TBL] [Abstract][Full Text] [Related]
32. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer. Schirrmacher V; Beckhove P; Choi C; Griesbach A; Mahnke Y Int J Oncol; 2005 Oct; 27(4):1141-9. PubMed ID: 16142333 [TBL] [Abstract][Full Text] [Related]
33. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. Kalinichenko VV; Mokyr MB; Graf LH; Cohen RL; Chambers DA J Immunol; 1999 Sep; 163(5):2492-9. PubMed ID: 10452985 [TBL] [Abstract][Full Text] [Related]
34. Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice. García-Pérez MA; Noguera I; Hermenegildo C; Martínez-Romero A; Tarín JJ; Cano A Hum Reprod; 2006 Apr; 21(4):880-7. PubMed ID: 16459351 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of effector cells mediating the antitumor action of glucan. Cook JA; Taylor D; Cohen C; Hoffmann EO; Rodrigue J; Malshet V; Di Luzio NR J Reticuloendothel Soc; 1977 Jul; 22(1):21-34. PubMed ID: 330854 [No Abstract] [Full Text] [Related]
36. [Sensitivity of bone marrow cells damaged by antitumor drugs to cytotoxic action of effectors of a normal spleen]. Klimova MIu; Bogdashin IV; Novitskiĭ VV; Gol'dberg ED Biull Eksp Biol Med; 1990 Jan; 109(1):60-2. PubMed ID: 2334801 [TBL] [Abstract][Full Text] [Related]
37. Immunomodulation of host resistance by tumor variants. Fuji H Transplant Proc; 1984 Apr; 16(2):460-2. PubMed ID: 6609454 [TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. Uchiyama T; Broder S; Waldmann TA J Immunol; 1981 Apr; 126(4):1393-7. PubMed ID: 6970774 [No Abstract] [Full Text] [Related]
40. Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V. Petro TM; Watson RR Cancer Res; 1982 Jun; 42(6):2139-45. PubMed ID: 6804089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]